Insider Spends US$110k Buying More Shares In Clover Health Investments
Investors who take an interest in Clover Health Investments, Corp. (NASDAQ:CLOV) should definitely note that the Independent Director, Anna Loengard, recently paid US$0.73 per share to buy US$110k worth of the stock. We reckon that's a good sign, especially since the purchase boosted their holding by 72%.
Check out our latest analysis for Clover Health Investments
The Last 12 Months Of Insider Transactions At Clover Health Investments
Notably, that recent purchase by Anna Loengard is the biggest insider purchase of Clover Health Investments shares that we've seen in the last year. We do like to see buying, but this purchase was made at well below the current price of US$0.82. Because the shares were purchased at a lower price, this particular buy doesn't tell us much about how insiders feel about the current share price.
Anna Loengard purchased 161.63k shares over the year. The average price per share was US$0.77. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!
Clover Health Investments is not the only stock insiders are buying. So take a peek at this free list of growing companies with insider buying.
Insider Ownership Of Clover Health Investments
Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. I reckon it's a good sign if insiders own a significant number of shares in the company. Insiders own 24% of Clover Health Investments shares, worth about US$98m. This level of insider ownership is good but just short of being particularly stand-out. It certainly does suggest a reasonable degree of alignment.
So What Does This Data Suggest About Clover Health Investments Insiders?
It's certainly positive to see the recent insider purchase. And an analysis of the transactions over the last year also gives us confidence. However, we note that the company didn't make a profit over the last twelve months, which makes us cautious. Given that insiders also own a fair bit of Clover Health Investments we think they are probably pretty confident of a bright future. While we like knowing what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. While conducting our analysis, we found that Clover Health Investments has 2 warning signs and it would be unwise to ignore them.
But note: Clover Health Investments may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
